Haeusler GM, Ammann RA, Carlesse F, Groll AH, Averbuch D, Castagnola E, Agyeman PKA, Phillips B, Gilli F, Solopova G, Attarbaschi A, Wegehaupt O, Speckmann C, Sung L, Lehrnbecher T (2021) SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: an analysis of 131 patients. Eur J Cancer 159:78–86

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mukkada S, Bhakta N, Chantada GL, Chen Y, Vedaraju Y, Faughnan L, Homsi MR, Muniz-Talavera H, Ranadive R, Metzger M, Friedrich P, Agulnik A, Jeha S, Lam C, Dalvi R, Hessissen L, Moreira DC, Santana VM, Sullivan M, Bouffet E, Caniza MA, Devidas M, Pritchard-Jones K, Rodriguez-Galindo C, Global Registry of C-iCC (2021) Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol 22:1416–1426

Article  PubMed  PubMed Central  CAS  Google Scholar 

Surie D, DeCuir J, Zhu Y, Gaglani M, Ginde AA, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, McNeal T, Ghamande S, Gibbs KW, Files DC, Hager DN, Ali H, Taghizadeh L, Gong MN, Mohamed A, Johnson NJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Khan A, Bender WS, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Kwon JH, Exline MC, Lauring AS, Shapiro NI, Columbus C, Halasa N, Chappell JD, Grijalva CG, Rice TW, Stubblefield WB, Baughman A, Womack KN, Rhoads JP, Hart KW, Swan SA, Lewis NM, McMorrow ML, Self WH, Network IVY (2022) Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19-associated hospitalization among immunocompetent adults aged ≥65 years - IVY network, 18 states, September 8-November 30, 2022. MMWR Morb Mortal Wkly Rep 71:1625–1630

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tenforde MW, Patel MM, Gaglani M, Ginde AA, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, McNeal T, Ghamande S, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CL, Busse LW, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Exline MC, Botros M, Lauring AS, Shapiro NI, Halasa N, Chappell JD, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Rhoads JP, Lindsell CJ, Hart KW, Zhu Y, Naioti EA, Adams K, Lewis NM, Surie D, McMorrow ML, Self WH, Network IVY (2022) Effectiveness of a third dose of Pfizer-BioNTech and Moderna vaccines in preventing COVID-19 hospitalization among immunocompetent and immunocompromised adults - United States, August-December 2021. MMWR Morb Mortal Wkly Rep 71:118–124

Article  PubMed  PubMed Central  CAS  Google Scholar 

Donze C, Min V, Ninove L, de Lamballerie X, Revon Riviere G, Verschuur A, Saultier P, Andre N (2023) BNT162b2 COVID-19 vaccines in children, adolescents and young adults with cancer-A 1-year follow-up. Vaccines (Basel) 11:989

Article  PubMed  CAS  Google Scholar 

Lehrnbecher T, Sack U, Speckmann C, Groll AH, Boldt A, Siebald B, Hettmer S, Demmerath EM, Reemtsma J, Schenk B, Ciesek S, Klusmann JH, Jassoy C, Hoehl S (2023) Longitudinal immune response to 3 doses of messenger RNA vaccine against coronavirus disease 2019 (COVID-19) in pediatric patients receiving chemotherapy for cancer. Clin Infect Dis 76:e510–e513

Article  PubMed  CAS  Google Scholar 

Revon-Riviere G, Ninove L, Min V, Rome A, Coze C, Verschuur A, de Lamballerie X, Andre N (2021) The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: a monocentric experience. Eur J Cancer 154:30–34

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020) Epidemiology of COVID-19 among children in china. Pediatrics 145:e20200702

Article  PubMed  Google Scholar 

Delbruck M, Hoehl S, Toptan T, Schenk B, Grikscheit K, Metzler M, Herrmann E, Ciesek S (2022) Low but recoverable markers of humoral immune response to BNT162b2 in elderly LTCF residents five to seven months after two-dose vaccination. Front Aging 3:883724

Article  PubMed  PubMed Central  Google Scholar 

Kruse M, Dark C, Aspden M, Cochrane D, Competiello R, Peltz M, Torres L, Wrighton-Smith P, Dudek M (2021) Performance of the T-SPOT().COVID test for detecting SARS-CoV-2-responsive T cells. Int J Infect Dis 113:155–161

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kannenberg J, Trawinski H, Henschler R, Buhmann R, Honemann M, Jassoy C (2022) Antibody course and memory B-cell response in the first year after SARS-CoV-2 infection. J Infect Dis 226:664–672

Article  PubMed  CAS  Google Scholar 

Piechotta VJK, Berner R, Bogdan C, Burchard G, Heininger U, Hummers E, von Kries R, Littmann MTL, Meerpohl J, Röbl-Mathieu MTM, van der Sande M, Sander LE, Terhardt M, Kü SV-B, Ow SW, Wiedermann-Schmidt U, Widders G, Zepp F (2023) Empfehlung der STIKO zur Implementierung der COVID-19-Impfung in die Empfehlungen der STIKO 2023 und die dazugehörige wissenschaftliche Begründung. Epid Bul 21:7–48

Google Scholar 

Paul E, Fancourt D (2022) Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: an observational study of 22,139 fully vaccinated adults in the UK. Lancet Reg Health Eur 14:100317

Article  PubMed  PubMed Central  Google Scholar 

Nelli F, Fabbri A, Virtuoso A, Giannarelli D, Giron Berrios JR, Marrucci E, Fiore C, Schirripa M, Signorelli C, Chilelli MG, Primi F, Pessina G, Natoni F, Silvestri MA, Ruggeri EM (2023) Effects of antibody response after booster vaccination on SARS-CoV-2 breakthrough infections and disease outcomes in advanced cancer patients: a prospective analysis of the vax-on-third study. Curr Oncol 30:5103–5115

Article  PubMed  PubMed Central  Google Scholar 

Barnes E, Goodyear CS, Willicombe M, Gaskell C, Siebert S, IdS T, Murray SM, Rea D, Snowden JA, Carroll M, Pirrie S, Bowden SJ, Dunachie SJ, Richter A, Lim Z, Satsangi J, Cook G, Pope A, Hughes A, Harrison M, Lim SH, Miller P, Klenerman P, Basu N, Gilmour A, Irwin S, Meacham G, Marjot T, Dimitriadis S, Kelleher P, Prendecki M, Clarke C, Mortimer P, McIntyre S, Selby R, Meardon N, Nguyen D, Tipton T, Longet S, Laidlaw S, Orchard K, Ireland G, Thomas D, Kearns P, Kirkham A, McInnes IB, consortium P, Consensus, Group OC (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nat Med 29:1760–1774

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lasagna A, Cassaniti I, Arena F, Bergami F, Percivalle E, Comolli G, Sarasini A, Ferrari A, Cicognini D, Schiavo R, Lo Cascio G, Pedrazzoli P, Baldanti F (2023) Persistence of immune response elicited by three doses of mRNA vaccine against SARS-CoV-2 in a cohort of patients with solid tumors: a one-year follow-up. Int J Mol Sci 24:6731

Article  PubMed  PubMed Central  CAS  Google Scholar